AAAAAA
Results: 26-48/48
Authors:
von Eckardstein, A
Nofer, JR
Assmann, G
Citation: A. Von Eckardstein et al., Acceleration of reverse cholesterol transport, CURR OPIN C, 15(5), 2000, pp. 348-354
Authors:
Tataru, MC
Heinrich, J
Junker, R
Schulte, H
von Eckardstein, A
Assmann, G
Koehler, E
Citation: Mc. Tataru et al., C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris, EUR HEART J, 21(12), 2000, pp. 1000-1008
Authors:
Schuler-Luttmann, S
Zhu, Y
Hoffmann, M
Marz, W
Feussner, G
Wieland, H
Assmann, G
von Eckardstein, A
Citation: S. Schuler-luttmann et al., Cholesterol efflux from normal and tangier disease fibroblasts into normal, high-density lipoprotein-deficient, and apolipoprotein E-deficient plasmas, METABOLISM, 49(6), 2000, pp. 770-777
Authors:
von Eckardstein, A
Schulte, H
Assmann, G
Citation: A. Von Eckardstein et al., Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: Implications for the definition of impaired fasting glucose by the American Diabetes Association, J CLIN END, 85(9), 2000, pp. 3101-3108
Authors:
Eue, I
Langer, C
von Eckardstein, A
Sorg, C
Citation: I. Eue et al., Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice, ATHEROSCLER, 151(2), 2000, pp. 593-597
Authors:
Nofer, JR
Fobker, M
Hobbel, G
Voss, R
Wolinska, I
Tepel, M
Zidek, W
Junker, R
Seedorf, U
von Eckardstein, A
Assmann, G
Walter, M
Citation: Jr. Nofer et al., Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux, BIOCHEM, 39(49), 2000, pp. 15199-15207
Authors:
Cullen, P
von Eckardstein, A
Souris, S
Schulte, H
Assmann, G
Citation: P. Cullen et al., Dyslipidaemia and cardiovascular risk in diabetes, DIABET OB M, 1(4), 1999, pp. 189-198
Authors:
Lee, M
von Eckardstein, A
Lindstedt, L
Assmann, G
Kovanen, PT
Citation: M. Lee et al., Depletion of pre beta(1)LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma, ART THROM V, 19(4), 1999, pp. 1066-1074
Authors:
Buchter, D
Behre, HM
Kliesch, S
Chirazi, A
Nieschlag, E
Assmann, G
von Eckardstein, A
Citation: D. Buchter et al., Effects of testosterone suppression in young men by the gonadotropin releasing hormone antagonist cetrorelix on plasma lipids, lipolytic enzymes, lipid transfer proteins, insulin, and leptin, EXP CL E D, 107(8), 1999, pp. 522-529
Authors:
Daum, U
Langer, C
Duverger, N
Emmanuel, F
Benoit, P
Denefle, P
Chirazi, A
Cullen, P
Pritchard, PH
Bruckert, E
Assmann, G
von Eckardstein, A
Citation: U. Daum et al., Apolipoprotein A-I(R151C)(Paris) is defective in activation of lecithin : cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux, J MOL MED-J, 77(8), 1999, pp. 614-622
Authors:
Bobak, M
Hense, HW
Kark, J
Kuch, B
Vojtisek, P
Sinnreich, R
Gostomzyk, J
Bui, M
von Eckardstein, A
Junker, R
Fobker, M
Schulte, H
Assmann, G
Marmot, M
Citation: M. Bobak et al., An ecological study of determinants of coronary heart disease rates: a comparison of Czech, Bavarian and Israeli men, INT J EPID, 28(3), 1999, pp. 437-444
Authors:
Schlegel, W
Petersdorf, LI
Junker, R
Schulte, H
Ebert, C
von Eckardstein, A
Citation: W. Schlegel et al., The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women, CLIN ENDOCR, 51(5), 1999, pp. 643-651
Authors:
Tataru, MC
Heinrich, J
Junker, R
Schulte, H
von Eckardstein, A
Assmann, G
Koehler, E
Citation: Mc. Tataru et al., D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction, EUR HEART J, 20(20), 1999, pp. 1493-1502
Authors:
Kleemann, A
Eckert, S
von Eckardstein, A
Lepper, W
Schernikau, U
Gleichmann, U
Hanrath, P
Fleck, E
Neiss, A
Kerber, S
Assmann, G
Breithardt, G
Citation: A. Kleemann et al., Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA - The Cholesterol LoweringAtherosclerosis PTCA Trial (CLAPT), EUR HEART J, 20(19), 1999, pp. 1393-1406
Authors:
Daum, U
Leren, TP
Langer, C
Chirazi, A
Cullen, P
Pritchard, PH
Assmann, G
von Eckardstein, A
Citation: U. Daum et al., Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I (R160L)(Oslo) and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers, J LIPID RES, 40(3), 1999, pp. 486-494
Authors:
Buchter, D
von Eckardstein, S
von Eckardstein, A
Kamischke, A
Simoni, M
Behre, HM
Nieschlag, E
Citation: D. Buchter et al., Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception, J CLIN END, 84(4), 1999, pp. 1244-1249
Authors:
Assmann, G
von Eckardstein, A
Nofer, JR
Walter, R
Citation: G. Assmann et al., Role of HDL in reverse cholesterol transport, ATHEROSCLER, 146, 1999, pp. S1-S1
Authors:
Hergenc, G
Schulte, H
Assmann, G
von Eckardstein, A
Citation: G. Hergenc et al., Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals, ATHEROSCLER, 145(1), 1999, pp. 147-156
Authors:
Saku, K
von Eckardstein, A
Zhang, B
Liu, R
Jimi, S
Ou, J
Ohta, T
Assmann, G
Arakawa, K
Citation: K. Saku et al., In vivo kinetics of human apolipoprotein A-I variants in rabbits, EUR J CL IN, 29(3), 1999, pp. 196-203
Authors:
von Eckardstein, A
Schulte, H
Assmann, G
Citation: A. Von Eckardstein et al., Increased risk of myocardial infarction in men with both hypertriglyceridemia and elevated HDL cholesterol, CIRCULATION, 99(14), 1999, pp. 1925-1925
Authors:
Nowak-Gottl, U
Junker, R
Hartmeier, M
Koch, HG
Munchow, N
Assmann, G
von Eckardstein, A
Citation: U. Nowak-gottl et al., Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood, CIRCULATION, 100(7), 1999, pp. 743-748
Authors:
Nowak-Gottl, U
Strater, R
Heinecke, A
Junker, R
Koch, HG
Schuierer, G
von Eckardstein, A
Citation: U. Nowak-gottl et al., Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood, BLOOD, 94(11), 1999, pp. 3678-3682
Authors:
Assmann, G
von Eckardstein, A
Citation: G. Assmann et A. Von Eckardstein, Tangier disease, LIPOPROTEINS IN HEALTH AND DISEASE, 1999, pp. 767-781